1. Acknowledgement

   Acknowledgments 13 September 2012 Pages: 757 - 758

2. Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Area Under the Concentration-Time Curve: Is This Clinically Useful for Dosage Prediction Yet?

   • Christine E. Staatz
   • Susan E. Tett

   Review Article 13 September 2012 Pages: 759 - 772

   

3. Kinetic Nomograms Assist Individualization of Drug Regimens

   • Hafedh Marouani
   • Anastasios Zografidis
   • Athanassios Iliadis

   Original Research Article 13 September 2012 Pages: 773 - 779

   

4. Effect of Cytochrome P450 3A4 Inducers on the Pharmacokinetic, Pharmacodynamic and Safety Profiles of Bortezomib in Patients with Multiple Myeloma or Non-Hodgkin’s Lymphoma

   • Andrzej Hellmann
   • Simon Rule
   • Vernon J. Louw

   Original Research Article 13 September 2012 Pages: 781 - 791

   

5. Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis

   • Liviawati Sutjandra
   • Rachelle D. Rodriguez
   • Juan José Pérez-Ruixo

   Original Research Article 13 September 2012 Pages: 793 - 807

   

6. Application of a Systems Approach to the Bottom-Up Assessment of Pharmacokinetics in Obese Patients

   • Cyrus Ghobadi
   • Trevor N. Johnson
   • Amin Rostami-Hodjegan

   Original Research Article 13 September 2012 Pages: 809 - 822

   

7. Population Pharmacokinetic/Pharmacodynamic Analyses as the Basis for Dosing of Therapeutic Monoclonal Antibodies

   • Bernd Meibohm

   Commentary 13 September 2012 Pages: 823 - 824

8. Obesity and Its Impact on Drug Therapy

   • Michael Neely
   • Stan Louie

   Commentary 13 September 2012 Pages: 825 - 826

9. Erratum to: Pharmacokinetics of antimalarials in pregnancy: a systematic review

   • K. J. Wilby
   • M. H. H. Ensom

   Erratum 13 September 2012 Pages: 827 - 827